Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-6bf8c574d5-mggfc Total loading time: 0 Render date: 2025-03-01T03:00:39.969Z Has data issue: false hasContentIssue false

Chapter 17 - Hepatitis A and hepatitis E virus infection

from Section III - Hepatitis and immune disorders

Published online by Cambridge University Press:  05 March 2014

By
Philip Rosenthal
Edited by
Frederick J. Suchy ,
Ronald J. Sokol  and
William F. Balistreri
Philip Rosenthal
Affiliation:
Pediatric Hepatology Director Pediatric Clinical Research, Departments of Pediatrics and Surgery and the Liver Center, the University of California, San Francisco, CA, USA
Frederick J. Suchy
Affiliation:
University of Colorado Medical Center
Ronald J. Sokol
Affiliation:
University of Colorado Medical Center
William F. Balistreri
Affiliation:
University of Cincinnati College of Medicine
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Liver Disease in Children , pp. 265 - 275
Publisher: Cambridge University Press
Print publication year: 2014

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Rezende, G, Roque-Afonso, AM, Samuel, D, et al. Viral and clinical factors associated with the fulminant course of hepatitis A infection. Hepatology 2003;38:613–618.CrossRefGoogle ScholarPubMed
Robertson, BH, Jansen, RW, Khanna, B, et al. Genetic relatedness of hepatitis A virus strains recovered from different geographical regions. J Gen Virol 1992;73:1365–1377.CrossRefGoogle ScholarPubMed
Fujiwara, K, Yokosuka, O, Fukai, K, et al. Analysis of full-length hepatitis A virus genome in sera from patients with fulminant and self-limited acute type A hepatitis. J Hepatol 2001;35:112–119.CrossRefGoogle ScholarPubMed
Taylor, GM, Goldin, RD, Karayiannis, P, et al. In situ hybridization studies in hepatitis A infection. Hepatology 1992;16:642–648.CrossRefGoogle ScholarPubMed
Ticehurst, JR, Racaniello, VR, Baroudy, BM, et al. Molecular cloning and characterization of hepatitis A virus cDNA. Proc Natl Acad Sci USA 1983;80:5885–5889.CrossRefGoogle ScholarPubMed
Koff, RS. Hepatitis A. Lancet 1998;351:1643–1649.CrossRefGoogle ScholarPubMed
Craig, AS, Schaffner, W. Prevention of hepatitis A with the hepatitis A vaccine. N Engl J Med 2004;350:476–481.CrossRefGoogle ScholarPubMed
Centers for Disease Control and Prevention. Hepatitis Surveillance Report 59. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, 2004:1–60.Google Scholar
Centers for Disease Control and Prevention. Hepatitits A outbreak associated with green onions at a restaurant – Monaca, Pennsylvania, 2003. MMWR Morb Mortal Wkly Rep 2003;52:1155–1157.Google Scholar
Wheeler, C, Vogt, TM, Armstrong, GL, et al. An outbreak of hepatitis A associated with green onions. N Engl J Med 2005;353:890–897.CrossRefGoogle ScholarPubMed
Hutin, YJF, Pool, V, Cramer, EH, et al. A multistate, foodborne outbreak of hepatitis A. N Engl J Med 1999;340:595–602.CrossRefGoogle ScholarPubMed
Weinberg, M, Hopkins, J, Farrington, L, et al. Hepatitis A in Hispanic children who live along the United States–Mexico border: the role of international travel and food-borne exposures. Pediatrics 2004;114:e68–73.CrossRefGoogle ScholarPubMed
Hadler, SC, Erben, JJ, Francis, DP, et al. Risk factors for hepatitis A in day-care centers, J Infect Dis 1982;145:255–261.CrossRefGoogle ScholarPubMed
Benenson, MW, Takafuji, ET, Bancroft, WH, et al. A military community outbreak of hepatitis type A related to transmission in a child care facility. Am J Epidemiol 1980;112:471–481.CrossRefGoogle Scholar
Vernon, AA, Schable, C, Francis, D. A large outbreak of hepatitis A in a daycare center: association with non-toilet-trained children and persistence of IgM antibody to hepatitis A virus. Am J Epidemiol 198;115:325–331.
Hadler, SC, Webster, HM, Erber, JJ, et al. Hepatitis A in day care centers: a community-wide assessment. N Engl J Med 1980;302:1222–1227.CrossRefGoogle ScholarPubMed
Balistreri, WF. Viral hepatitis. Emerg Clin North Am 1991;9:365–399.Google Scholar
Leach, C. Hepatitis A in the United States. Pediatr Infect Dis J 2004;23:551–552.CrossRefGoogle ScholarPubMed
Jung, YM, Park, SJ, Kim, JS et al. Atypical manifestations of hepatitis A infection: a prospective, multicenter study in Korea. J Med Virol. 2010;82:1318–1326.CrossRefGoogle ScholarPubMed
Rachima, CM, Cohen, E, Garty, M. Acute hepatitis A: combination of relapsing and the cholestatic forms, two rare variants. Am J Med Sci 2000;319:417–419.CrossRefGoogle ScholarPubMed
Schiff, ER. Atypical clinical manifestations of hepatitis A. Vaccine 1992;10(Suppl 1):S18–S20.CrossRefGoogle ScholarPubMed
Ozcay, F, Canan, O, Akcan, B, et al. Hepatitis A super infection as a cause of liver failure in a child with Wilson’s disease. Turk J Pediatr 2007;49:199–202.Google Scholar
Ciocca, M, Moreira-Silva, SF, Alegria, S, et al. Hepatitis A as an etiologic agent of acute liver failure in Latin America. Pediatr Infect Dis J 2007;26:711–715.CrossRefGoogle ScholarPubMed
Centers for Disease Control and Prevention. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1999;48:1–39.Google Scholar
Kim, HY, Eyheramonho, MB, Pichavant, M, et al. A polymorphism in TIM1 is associated with susceptibility to severe hepatitis A virus infection in humans. J Clin Invest 2011;121:1111–1118.CrossRefGoogle ScholarPubMed
Arora, NK, Mathur, P, Ahuja, A, Oberoi, A. Acute liver failure. Indian J Pediatr 2003;70:73–79.CrossRefGoogle ScholarPubMed
Amon, JJ, Darling, N, Fiore, AE et al. Factors associated with hepatitis A vaccination among children 24 to 35 months of age: United States, 2003. Pediatrics 2006;117:30–33.CrossRefGoogle ScholarPubMed
Centers for Disease Control and Prevention. Vaccines and Immunizations. Atlanta, GA: Centers for Disease Control and Prevention, 2010 (, accessed 22 July 2013).Google Scholar
Centers for Disease Control and Prevention. Vaccine Recommendations of the Advisory Committee for Immunization Practices. Atlanta, GA: Centers for Disease Control and Prevention, 2013 (, accessed 22 July 2013).Google Scholar
Landry, P, Tremblay, S, Darioli, R, Genton, B. Inactivated hepatitis A vaccine booster given ≥24 months after the primary doses. Vaccine 2000;19:399–402.CrossRefGoogle Scholar
McMahon, BJ, Williams, J, Bulkow, L, et al. Immunogenicity of an inactivated hepatitis A vaccine in Alaska native children and native and non-native adults. J Infect Dis 1995;17:676–679.CrossRefGoogle Scholar
Horng, YC, Chang, MH, Lee, CY, et al. Safety and immunogenicity of hepatitis A vaccine in healthy children. Pediatr Infect Dis J 1993;12:359–362.CrossRefGoogle ScholarPubMed
Balcarek, KB, Bagley, MR, Pass, RF, Schiff, ER, Krause, DS. Safety and immunogenicity of an inactivated hepatitis A vaccine in preschool children. J Infect Dis 1995;171(Suppl 1):S70–S72.CrossRefGoogle ScholarPubMed
Ashur, Y, Adler, R, Rowe, M, Shouval, D. Comparison of immunogenicity of two hepatitis A vaccines – VAQTA and HAVRIX – in young adults. Vaccine 1999;17:2290–2296.CrossRefGoogle ScholarPubMed
Letson, GW, Shapiro, CN, Kuehn, D, et al. Effect of maternal antibody on immunogenicity of hepatitis A vaccine in infants. J Pediatr 2004;144:327–332.CrossRefGoogle ScholarPubMed
Das, A. An economic analysis of different strategies of immunization against hepatitis A virus in developed countries. Hepatology 1999;29:548–552.CrossRefGoogle ScholarPubMed
Werzberger, A, Mensch, B, Kuter, B, et al. A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. N Engl J Med 1992;327:453–457.CrossRefGoogle ScholarPubMed
Innis, BL, Snithhan, R, Kunasol, P, et al. Protection against hepatitis A by an inactivated vaccine. JAMA 1994;271:1328–1334.CrossRefGoogle ScholarPubMed
Gouvea, AF, De Moraes-pinto, MI, Ono, E, et al. Immunogenicity and tolerability of hepatitis A vaccine in HIV-infected children. Clin Infect Dis 2005;41:544–548.CrossRefGoogle ScholarPubMed
Siberry, GK, Coller, RJ, Henkle, E, et al. Antibody response to hepatitis A immunization among human immunodeficiency virus-infected children and adolescents. Pediatr Infect Dis J 2008;27:465–468.CrossRefGoogle ScholarPubMed
Weinberg, A, Gona, P, Nachman, SA, et al. Antibody-response to hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active retroviral therapy. J Infect Dis 2006;193:302–311.CrossRefGoogle Scholar
Arslan, M, Wiesner, RH, Poterucha, JJ, Zein, NN. Safety and efficacy of hepatitis A vaccination in liver transplantation recipients. Transplantation 2001;72:272–276.CrossRefGoogle ScholarPubMed
Diana, A, Posfay-Barbe, KM, Belli, DC, Siegrist, CA. Vaccine-induced immunity in children after orthotopic liver transplantation: a 12-yr review of the Swiss national reference center. Pediatr Transplant 2007;11:31–37.CrossRefGoogle ScholarPubMed
Lee, SD, Chan, CY, Yu, MI, et al. Safety and immunogenicity of inactivated hepatitis A vaccine in patients with chronic liver disease. J Med Virol 1997;52:215–218.3.0.CO;2-J>CrossRefGoogle ScholarPubMed
Keeffe, EB, Iwarson, S, McMahon, BJ, et al. Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease. Hepatology 1998;27:881–886.CrossRefGoogle ScholarPubMed
Ferreira, CT, da Silviera, TR, Viera, SM et al. Immunogenicity and safety of hepatitis A vaccine in children with chronic liver disease. J Pediatr Gastroenterol Nutr 2003;37:258–261.CrossRefGoogle ScholarPubMed
El-Karaksy, HM, El-Hawary, MI, El-koofy, NM, et al. Safety and efficacy of hepatitis A vaccine in children with chronic liver disease. World J Gastroenterol 2006;12:7337–7340.CrossRefGoogle ScholarPubMed
Majda-Stanislawska, E, Bednarek, M, Kuydowicz, J. Immunogenicity of inactivated hepatitis A vaccine in children with chronic liver disease. Pediatr Infect Dis J 2004;23:571–574.CrossRefGoogle ScholarPubMed
Troisi, CL, Hollinger, FB, Krause, DS, et al. Immunization of seronegative infants with hepatitis A vaccine (HAVRIX®; SKB): a comparative study of two dosing schedules. Vaccine 1997;15:1613–1617.CrossRefGoogle Scholar
Piazza, M, Safary, A, Vegnente, A, et al. Safety and immunogenicity of hepatitis A vaccine in infants: a candidate for inclusion in the childhood vaccination programme. Vaccine 1999;17:585–588.CrossRefGoogle ScholarPubMed
Dagan, R, Amir, J, Mijalovsky, A, et al. Immunization against hepatitis A in the first year of life: priming despite the presence of maternal antibody. Pediatr Infect Dis J 2000;19:1045–1052.CrossRefGoogle ScholarPubMed
Fiore, AE, Shapiro, CN, Sabin, K, et al. Hepatitis A vaccination of infants: effect of maternal antibody status on antibody persistence and response to a booster dose. Pediatr Infect Dis J 2003;22:354–359.CrossRefGoogle ScholarPubMed
Hammitt, LL, Bulkow, L, Hennessy, TW, et al. Persistence of antibody to hepatitis A virus 10 years after vaccination among children and adults. J Infect Dis 2008;198:1776–1782.CrossRefGoogle ScholarPubMed
Werzberger, A, Mensch, B, Nalin, DR, Kuter, BJ. Effectiveness of hepatitis A vaccine in a former frequently affected community: 9 years’ followup after the Monroe field trial of VAQTA. Vaccine 2002;20:1699–1701.CrossRefGoogle Scholar
Chang, CY, Lee, SD, Yu, MI, et al. Long-term follow-up of hepatitis A vaccination in children. Vaccine 1999;17:369–372.CrossRefGoogle Scholar
Van Damme, P, Banatvala, J, Fay, O, et al. Hepatitis A booster vacination: is there a need? Lancet 2003;362:1065–1071.CrossRefGoogle Scholar
Van Herckk, K, Van Damme, P. Inactivated hepatitis A vaccine-induced antibodies: follow-up and estimates of long-term persistence. J Med Virol 2001;63:1–7.3.0.CO;2-U>CrossRefGoogle Scholar
Centers for Disease Control and Prevention. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2006;55(RR-7):1–23.Google Scholar
Rosenthal, P. Cost-effectiveness of hepatitis A vaccination in children, adolescents, and adults. Hepatology 2003;37:44–51.CrossRefGoogle Scholar
Ansari, IH, Nanda, SK, Durgapal, H, et al. Cloning sequencing, and expression of the hepatitis E virus (HEV) nonstructural open reading frame 1. J Med Virol 2000;60:275–283.3.0.CO;2-9>CrossRefGoogle ScholarPubMed
Krawczynski, K, Aggarwal, R, Kamili, S. Infections of the liver. Infect Dis Clin N Am 2000;14:1–18.Google Scholar
Worm, HC, van der Poel, WHM, Brandstatter, G. Hepatitis E: an overview. Microbes Infect 2002;4:657–666.CrossRefGoogle ScholarPubMed
Aggarwal, R, Krawczynski, K. Hepatitis E: an overview and recent advances in clinical and laboratory research. J Gastroenterol Hepatol 2000;15:9–20.CrossRefGoogle ScholarPubMed
Ahn, J-M, Kang, S-G, Lee, D-Y, et al. Identification of novel human hepatitis E virus (HEV) isolates and determination of the seroprevalence of HEV in Korea. J Clin Microbiol 2005;3042–3048.CrossRefGoogle ScholarPubMed
Tam, AW, Smith, MM, Guerra, ME, et al. Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology 1991;185:120–131.CrossRefGoogle ScholarPubMed
Reyes, GR, Purdy, MA, Kim, JP, et al. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science 1990;247:1335–1339.CrossRefGoogle ScholarPubMed
Shrestha, SM, Srestha, S, Tsuda, F, et al. Genetic changes in hepatitis E virus of subtype 1a in patients with sporadic acute hepatitis E in Kathmandu, Nepal, from 1997 to 2002. J Gen Virol 2004;85:97–104.CrossRefGoogle ScholarPubMed
Mansuy, JM, Peron, JM, Abravanel, F, et al. Hepatitis E in the south west of France in individuals who have never visited an endemic area. J Med Virol 2004;74:419–424.CrossRefGoogle ScholarPubMed
Redlinger, T, O’Rourke, K, Nickey, L, Martinez, G. Elevated hepatitis A and E seroprevalence rates in a Texas/Mexico border community. Tex Med 1998;94:68–71.Google Scholar
Aggarwal, R, Naik, SR. Faecal excretion of hepatitis-E virus. Lancet 1992;340:787.CrossRefGoogle ScholarPubMed
DeCock, KM, Bradley, DW, Sandford, NL, et al. Epidemic non-A, non-B hepatitis in patients from Pakistan. Ann Intern Med 1987;106:227–230.CrossRefGoogle Scholar
Ray, R, Aggarwal, R, Salunke, PN, et al. Hepatitis E virus genome in stools of hepatitis patients during large epidemic in North India, Lancet 1991;338:783–784.CrossRefGoogle ScholarPubMed
Skidmore, SJ, Yarbough, PO, Gabor, KA, et al. Hepatitis E virus: the cause of waterborne hepatitis outbreak. J Med Virol 1992;37:58–60.CrossRefGoogle Scholar
Ticehurst, J, Popkin, TJ, Bryan, JP, et al. Association of hepatitis E virus with an outbreak of hepatitis in Pakistan: serologic responses and pattern of virus excretion. J Med Virol 1992;36:84–92.CrossRefGoogle ScholarPubMed
Chauhan, A, Dilawari, JB, Jameel, S, et al. Common etiological agent for epidemic and sporadic non-A non-B hepatitis. Lancet 1992;339:1509–1510.CrossRefGoogle Scholar
Hau, CH, Hien, TT, Tien, NT, et al. Prevalence of enteric hepatitis A and E viruses in the Mekong delta region of Vietnam. Am J Trop Med Hyg 1998;60:277–280.CrossRefGoogle Scholar
Goto, K, Ito, K, Sugiura, T, et al. Prevalence of hepatitis E virus infection in Japanese children. J Pediatr Gastroenterol Nutr 2005;42:89–92.CrossRefGoogle Scholar
Emerson, SU, Purcell, RH. Running like water: the omnipresence of hepatitis E. N Engl J Med 2004;351:2367–2368.CrossRefGoogle ScholarPubMed
Bader, TF, Krawczynski, K, Polish, LB, et al. Hepatitis E in a US traveler to Mexico. N Engl J Med 1991;325:1659.Google Scholar
De Groen, PC. Hepatitis E in the United States: a case of “hog fever?”Mayo Clin Proc 1997;72:1197–1198.CrossRefGoogle ScholarPubMed
Goldsmith, R, Yarbough, PO, Reyes, GR, et al. Enzyme-linked immunosorbent assay for diagnosis of acute sporadic hepatitis E in Egyptian children. Lancet 1992;339:328–332.CrossRefGoogle ScholarPubMed
Hyams, KC, Purdy, MA, Kaur, M, et al. Acute sporadic hepatitis E in Sudanese children: analysis based on a new Western blot assay. J Infect Dis 1992;165:1001–1005.CrossRefGoogle ScholarPubMed
Daniel, HDJ, Warier, A, Abraham, P, Sridharan, G. Age-wise exposure rates to hepatitis E virus in a southern Indian patient population without liver disease. Am J Top Med Hyg 2004;71:675–678.Google Scholar
Khuroo, MS, Kamili, S, Yattoo, GN. Hepatitis E virus infection may be transmitted through blood transfusions in an endemic area. J Gastroenterol Hepatol 2004;19:778–784.CrossRefGoogle Scholar
Singh, S, Mohanty, A, Joshi, YK, et al. Mother-to-child transmission of hepatitis E virus infection. Indian J Pediatr 2003;70:37–39, 597.CrossRefGoogle ScholarPubMed
Khuroo, MS, Kamili, S, Jameel, S. Vertical transmission of hepatitis E virus. Lancet 1995;345:1025–1026.CrossRefGoogle ScholarPubMed
Kumar, RM, Uduman, S, Rana, S, et al. Sero-prevalence and mother-to-infant transmission of hepatitis E virus among pregnant women in the United Arab Emirates. Eur J Obstet Gynecol Reprod Biol 2001;100:9–15.CrossRefGoogle ScholarPubMed
Arora, NK, Panda, SK, Nanda, SK, et al. Hepatitis E infection in children: study of an outbreak. J Gastroenterol Hepatol 1999;14:572–577.CrossRefGoogle ScholarPubMed
Worm, HC, van der Poel, WHM, Brandstatter, G. Hepatitis E: an overview. Microbes Infect 2002;4:657–666.CrossRefGoogle ScholarPubMed
Panda, SK, Jameel, S. Hepatitis E virus: from epidemiology to molecular biology. Viral Hepat 1997;3:227–251.Google Scholar
Kamar, N, Mansuy, JM, Cointault, O, et al. Hepatitis E virus-related cirrhosis in kidney- and kidney-pancreas-transplant recipients. Am J Transplant 2008;8:1744–1748.CrossRefGoogle ScholarPubMed
Kamar, N, Garrouste, C, Haagsma, EB, et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology 2011;140:1481–1489.CrossRefGoogle ScholarPubMed
Hamid, SS, Atiq, M, Shehzad, F, et al. Hepatitis E virus superinfection in patients with chronic liver disease. Hepatology 2002;36:474–478.CrossRefGoogle ScholarPubMed
Kumar, A, Aggarwal, R, Naik, SR, et al. Hepatitis E virus is responsible for decompensation of chronic liver disease in an endemic region. Indian J Gastroenterol 2004;23:59–62.Google Scholar
Ramachandran, J, Eapen, CE, Kang, G, et al. Hepatitis E superinfection produces severe decompensation in patients with chronic liver disease. J Gastroenterol Hepatol 2004;19:134–138.CrossRefGoogle ScholarPubMed
Davern, TJ, Chalasani, N, Fontana, RJ, et al. Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. Gastroenterology 2011;14:1665–1672.CrossRefGoogle Scholar
Bile, K, Isse, A, Mohamud, O, et al. Contrasting roles of rivers and wells as sources of drinking water on attack and fatality rates in a hepatitis E epidemic in Somalia. Am J Trop Med Hyg 1994;51:466–474.CrossRefGoogle Scholar
Corwin, AL, Khiem, HB, Clayson, ET, et al. A waterborne outbreak of hepatitis E virus transmission in southwestern Vietnam. Am J Trop Med Hyg 1996;54:559–562.CrossRefGoogle ScholarPubMed
Khuroo, MS, Dar, MY. Hepatitis E: Evidence for person-to-person transmission and inability of low dose immune serum globulin from an Indian source to prevent it. Indian J Gastroenterol 1992;3:113–116.Google Scholar
Tsarev, SA, Tsareva, TS, Emerson, SU, et al. Successful passive and active immunization of cynomolgus monkeys against hepatitis E. Proc Natl Acad Sci USA 1994;91:10198–10202.CrossRefGoogle ScholarPubMed
Tsarev, SA, Tsareva, TS, Emerson, SU, et al. Recombinant vaccine against hepatitis E: dose response and protection against heterologous challenge. Vaccine 1997;15:1834–1838.CrossRefGoogle ScholarPubMed
Kamili, S. Toward the development of a hepatitis E vaccine. Virus Res 2011;161:93–100.CrossRefGoogle ScholarPubMed
Alric, L, Bonnet, D, Laurent, G, et al. Chronic hepatitis E virus infection: successful virologic response to pegylated interferon-alpha therapy. Ann Intern Med 2010;153:135–136.CrossRefGoogle Scholar
Kamar, N, Rostaing, L, Abravanel, F, et al. Ribavirin therapy inhibits viral replication in patients with chronic hepatitis E virus infection. Gastroenterology 2010;139:1612–1618.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×